Magnitude of Metabolic Syndrome and Associated Factors Among Renal Transplant Recipients at St. Paul Hospital’s National Kidney Transplant Centre: A New Centre Experience; April to July, 2018.

  • Leja Hamza


Introduction: Metabolic syndrome (MS) is a cluster of risk factors for cardiovascular diseases (CVD). It is also common in renal transplant recipients and is associated with increased risk of graft dysfunction and cardiovascular mortality. Its magnitude is not known in our Ethiopian patients.

Objective: To determine the magnitude of metabolic syndrome and associated factors.

Methods: Analytical cross-sectional design was used. Eighty-seven Ethiopian renal transplant recipients having follow-up at St. Paul Hospital’s National Kidney Transplant Centre were studied from May to July, 2018. A structured data collection format was used to collect data. ContextualizedWHO STEPS Instrument for Non-communicable Diseases Risk Factor Surveillance” was utilized for collecting data on behavioral risk factors, biophysical measurements and laboratory tests. 

 Results: Majority of the patients were males, 64 (73.6%). Most of them were young with mean age of 35.8 (+11.9) years. Hypertension (HPN) was the commonest component of MS accounting for 49 (56.3%) of cases. The magnitude of metabolic syndrome was 34.5%. Only central obesity (P. value = 0.046; AOR 39.1 (1.1, 141) and hyperglycemia (P=0.031; AOR 25.1(1.3, 467.8) were significantly associated with metabolic syndrome.

Conclusion and Recommendations: The magnitude of MS was high in our transplant recipients. However, only waist circumference and hyperglycemia were found to have significant association with MS. Comprehensive preventive strategies should be implemented for management of MS to minimize its impact.

Key Words: Metabolic syndrome, renal transplant, DM, HPN, Dyslipidemia, Central Obesity, Ethiopia.


1. Rakesh M. Parikh, Viswanathan Mohan. Changing definitions of metabolic syndrome. Indian J Endocrinol Metab. 2012 Jan-Feb; 16(1):7-12.
2. Paul L. Huang et al. A comprehensive definition for metabolic syndrome. Dis Model Mech. 2009 May-Jun;2(5-6):231-7.
3. Jing Liu SMG, Wei Wang, Sidney C. Smith et al. Ethnic-Specific Criteria for the Metabolic Syndrome; Evidence from China. Diabetes Care. 2006 Jun; 29(6):1414-6.
4. Awsan et al. Metabolic syndrome. Global Advanced Research Journal of Medicine and Medical Sciences. 2013; 2(11):238-46.
5. Emma-Okon, Onayade, Adegoke. Metabolic syndrome in an elite African community. African Journal of Diabetes Medicine. Nov. 2013; 21(2):42.
6. Scott M. Grundy, H. Bryan Brewer Jr, James I. Cleeman, Sidney C. Smith Jr, Claude Lenfant. A new IDF woldwide definition of the metabolic syndrome: the rationale and the results. IDF 2004;50(3):109-433.
7. P. Anil Kumar, P. Swathi Chitra et al. Metabolic syndrome and associated chronic kidney diseases: Nutritional interventions. Reviews in Endocrine and Metabolic Disorders. September 2013;14(3):273–86.
8. Ishu Kataria RC, Renuka Pathak. Dietary and lifestyle modification in metabolic syndrome: a review of randomized control trials in different population groups. Reviews in Health Care. 2013;4(4):209-30.
9. Courivaud C, Kazory A, Simula-Faivre D, Chalopin JM, Ducloux D. Metabolic syndrome and atherosclerotic events in renal transplant recipients. Transplantation. 2007; 83:1577-81.
10. Donald E. Hricik. Metabolic Syndrome in Kidney Transplantation: Management of Risk Factors. Clin J Am Soc Nephrol. 2011;6:1781-5.
11. Anonimous. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001; 285(3):2486 – 97.
12. Anushree C, Shirali, Margaret J. Management of Cardiovascular Disease in Renal Transplant Recipients. CJASN February 20, 2008.
13. Chen J MP, Hamm LL, Jones DW, Batuman V, Fonseca V, Whelton PK, He J. The metabolic syndrome and chronic kidney disease in U.S. adults. . Ann Intern Med 2004 Feb 3;140(3):167-74.
14. M. Oruc K, Koseoglua N, Seyahi S, Alagoz S, Trabulus M, R.Altiparmak. Progression of Metabolic Syndrome in Renal Transplant Recipients. Transplantation Proceedings. November 2013; 45(9):3273-8.
15. Nabeel A. Bapoo, Johan D. Nel. New Onset Diabetes after Transplantation in Renal Transplant Recipients at Tygerberg Hospital, South Africa. African Journal of Nephrology. 2014; 17(1).
16. Samira Ebrahimof, Parvin Mirmiran. Nutritional Approaches for Prevantion and Treatment of Metabolic Syndrome in Adults. Journal of Paramedical Sciences (JPS). Spring 2013; 4(2):ISSN 2008-4978.
17. Assumpta Ensenyat LM, Francisco José Verdejo et al. Metabolic risk management, physical exercise and lifestyle counselling in low-active adults: controlled randomized trial (BELLUGAT). BMC Public Health. March 14, 2017;17(257).
18. Azadbakht L MP, Esmaillzadeh A, Azizi T, Azizi F. Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes care 28(12):2823-31.
19. Kastorini CM MH, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB. The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. Journal of the American College of Cardiology 2011;57(11):1299-313.
20. WHO. Global recommendations on physical activity for health WHO Press. 2010:pp 58.
21. Jardine AG HH, fellstrom B et al. Fluvastatin prevents cardiac death and myocardial infarction in renal transplant recipients: Post-hoc subgroup analyses of the ALERT study. Am J Transplant 2004.
22. WHO. WHO Step wise approach to chronic Disease Risk-Factor Surveillance WHO Manual.
23. Elkehili IM ea. Prevalence of the Metabolic Syndrome. Arab J Nephrol Transplant. 2012.
24. Hami M SM, Sefidgaran A, Mojahedi MJ. Prevalence of the metabolic syndrome in kidney transplant recipients: A single-center study. Saudi J Kidney Dis Transpl. 2017 Mar-Apr;28(2):362-7.
25. Toahihide N. JU, Tasuya N. The prevalence of metabolic syndrome in Japanese renal transplant recipients. 10 May 2007.
26. Tabassum Elahi FA, Ejaz Ahmed, Rubina Naqvi. Prevalence of Metabolic Syndrome in renal transplant recipients - a single centre experience. JPMA. August 2009;Vol. 59(No. 8).
27. Bras. J. Prevalence of metabolic syndrome and its associated factors in renal transplant recipients. Brazilian Journal of Nephrogy. Jan-Mar, 2012;34(1).
28. Goldsmith D PC. The metabolic syndrome following kidney transplantation. Kidney Int 2010; 78 (Suppl 118): S8–S14 2010;78(Suppl 118):S8-S14.
29. Zana Sidiq, Mohammed Saleem. Metabolic syndrome in renal transplant recipients in Duhok Kidney Diseases Center. Transplantation Reports. October 2016;1(1-2):7-10.
30. Fezeu L BB, Kengne A, Sobngwi E, Mbanya J. Metabolic syndrome in a sub-Saharan African setting: central obesity may be the key determinant. . Atherosclerosis. 2007 Jul 193(1):70-6.
31. CY Cheung HC, YL Liu, YH Chan, HS Wong, WL Chak, KS Choi, KF Chau, CS Li Prevalence of metabolic syndrome in Chinese renal transplant recipients. Hong Kong Med J 2008;14(379):84.